tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
PHAS is currently covered by 1 analysts with an average price target of $4.6. This is a potential upside of $4.6 (0%) from yesterday's end of day stock price of $0.
PhaseBio Pharmaceuticals's activity chart (see below) currently has 26 price targets and 19 ratings on display. The stock rating distribution of PHAS is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 2.86% with an average time for these price targets to be met of 21.14 days.
Most recent stock forecast was given by ANNABEL SAMIMY from STIFEL on 28-Sep-2022.
Currently out of the existing stock ratings of PHAS, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
1
$0.96 (2400.00%)
15
1 years 6 months 27 days ago
0/2 (0%)
$0.74 (284.62%)
Buy
2 years 6 months 11 days ago
0/1 (0%)
$6.27 (132.56%)
Buy
15
$14.96 (37400.00%)
2 years 10 months 7 days ago
0/3 (0%)
$11.02 (276.88%)
Buy
10
$9.96 (24900.00%)
12
3 years 7 months 30 days ago
0/6 (0%)
$6.2 (163.16%)
Buy
14
$13.96 (34900.00%)
17
3 years 10 months 27 days ago
1/5 (20%)
$7.98 (132.56%)
148
What is PHAS (PhaseBio Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on PHAS (PhaseBio Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on PHAS (PhaseBio Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on PHAS (PhaseBio Pharmaceuticals)?
Which analyst is the currently most bullish on PHAS (PhaseBio Pharmaceuticals)?
Which analyst is the currently most reserved on PHAS (PhaseBio Pharmaceuticals)?
